Levofloxacin Injection, Solution, Concentrate
Product Images NDC 55150-156

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 55150-156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)

A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 750 mg' comparing plasma concentration (mcg/mL) over time (hours) for 750 mg Levofloxacin tablet (oral) and 750 mg intravenous infusion over 90 minutes. It shows plasma concentration peaking quickly after IV infusion with a sharp rise, while oral tablet peaks slightly later, followed by a decline for both over 36 hours.*

FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)

A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg' showing plasma concentration (mcg/mL) on the y-axis and time (hours) on the x-axis. It compares 500 mg oral tablet and 500 mg intravenous (i.v.) administration, with plasma concentration rising quickly for i.v. dose and both curves declining over 36 hours.*

FDA Label Image

Package Label-principal Display Panel (500 mg per 20 mL Container Label)

Label for Levofloxacin Injection 500 mg per 20 mL (25 mg/mL) intravenous injection concentrate. The label includes directions for use, storage instructions, and formulation details. Distributed by AuroMedics Pharma LLC and made in India. The container size is 20 mL.*

FDA Label Image

Package Label-principal Display Panel (500 mg per 20 mL Container-Carton (1 Vial))

The packaging label for Levofloxacin Injection 500 mg per 20 mL (25 mg/mL) intravenous infusion concentrate by Auromedics Pharma LLC. The carton includes directions for use stating it is a single-dose vial requiring dilution before intravenous administration, storage instructions, and a note that the vial stopper is latex-free. The label also displays the NDC 55150-156-20, distributor address, barcode, and the Auromedics logo.*

FDA Label Image

Package Label-principal Display Panel (750 mg per 30 mL Container Label)

Label for Levofloxacin Injection 750 mg per 30 mL (25 mg/mL) concentrate for intravenous infusion. The label includes usage directions as a single-dose vial requiring dilution before administration, storage instructions at controlled room temperature, and pH range details. Distributed by AuroMedics Pharma LLC and made in India. The vial contains 30 mL of solution, Rx only.*

FDA Label Image

Package Label-principal Display Panel (750 mg per 30 mL Container-Carton (1 Vial))

Levofloxacin Injection 750 mg per 30 mL (25 mg/mL) intravenous injection concentrate carton label distributed by Auromedics Pharma LLC. The label includes directions for use, storage conditions, and pharmacist dispensing instructions. It specifies the product is for intravenous infusion after dilution and contains 30 mL per vial. The label also features barcodes and the Auromedics logo.*

FDA Label Image

Chemical Structure (Levofloxacin Str)

Chemical structure of levofloxacin monohydrate, showing the molecular arrangement including a fluorine atom, carboxyl group, and lactone ring, along with the half molecule of water (1/2 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.